Closed
SectorHealthcare
105.94 2.26
24h
Min
104.29
Max
106.33
Income | -11M -42M |
---|---|
Sales | 2.5M 45M |
P/E Sector Avg | 47.016 51.198 |
EPS | 1.33 |
Profit margin | -93.643 |
Employees | 68 |
EBITDA | -11M -41M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +43.18% upside |
Next Earnings | 5 sie 2025 |
---|
Market Cap | -46M 2B |
---|---|
Previous open | 103.68 |
Previous close | 105.94 |
By Acuity
13%
87%
14 / 380 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 149.17 USD 43.18%
High 160 USD
Low 135 USD
Based on 7 Wall Street analysts offering 12 month price targets forLigand Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$